Health Care & Life Sciences » Pharmaceuticals | Celltrion Pharm Inc.

Celltrion Pharm Inc.

Celltrion Pharm Inc.
Stock Exchange Korea Exchange
EPS
KRW204.41
Market Cap
KRW2.72 T
Shares Outstanding
34.04 M
Public Float
15.23 M

Profile

Address
82 2sandan-ro
Cheongju-si NC 28117
Korea, Republic Of
Employees -
Website http://www.celltrionph.com
Updated 09/14/2018
Celltrion Pharm, Inc. engages in the manufacture and sale of pharmaceuticals. Its products are categorized into the following: the group of medicine effect, biosimilars and over-the-counter (OTC) drug. The group of medicine effect includes hepatotonics, hepatotonics and anti-inflammatory drugs, antihistamine, respiratory apparatus drugs, circulatory system drug, digestives and stomachics drug, hormone and metabolic disease drugs, antibiotics and antimycotic, nutrientia and tonic, immunology, oncology, and the other drugs.

Financials

View All
Created with Highcharts 5.0.14Celltrion Pharm Inc.Net Income. Fiscal year is January-December. All values KRW Millions.2 6132 6135 8695 8696 7346 7342 9162 9162 8772 8772013201420152016201702k4k6k8k
Created with Highcharts 5.0.14Celltrion Pharm Inc.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.52 65752 65766 74466 74474 73274 732104 811104 811135 860135 86020132014201520162017025k50k75k100k125k150k

Jung-Jin Seo
Chairman
Jeong-Soo Suh
Chief Executive Officer & Director